Immune and tissue microenvironment (TME/IME)

The immune and tissue microenvironment (TME/IME) is a complex, multi-component ecosystem consisting of various cell types, including immune cells, fibroblasts, and endothelial cells, as well as the extracellular matrix and signaling molecules like cytokines and chemokines (Nature Reviews Cancer, 2017). It is not a single molecular target but rather a dynamic environment that regulates tissue homeostasis and disease progression, particularly in cancer and chronic inflammation (Cell, 2017). In the context of oncology, the tumor microenvironment often becomes immunosuppressive, utilizing regulatory T cells and inhibitory cytokines to evade the host immune system (PubMed, 2021). Therapeutic strategies aimed at the microenvironment do not target the system as a whole but rather specific components within it, such as immune checkpoints (e.g., PD-1/PD-L1) or angiogenic factors (e.g., VEGF) (NIH, 2023). These interventions seek to reprogram the environment to favor immune activation and inhibit tumor growth. However, the high degree of spatial and temporal heterogeneity within the microenvironment poses significant challenges for drug delivery and the development of resistance (StatPearls, 2023). Monitoring biomarkers like tumor-infiltrating lymphocytes and PD-L1 expression is critical for selecting patients likely to benefit from these microenvironment-modulating therapies.

Other names

Tumor microenvironmentTissue microenvironmentImmune microenvironmentStromaCellular niche

Modulation of the cellular and molecular components within a specific tissue area to restore homeostasis or enhance anti-tumor immunity.